Etacizin

Etatsizin is a drug that is prescribed for extrasystoles, atrial fibrillation and other heart rhythm disorders, as well as for early repolarization syndrome of the ventricular myocardium and other heart diseases. It belongs to the antiarrhythmic group of drugs and is used under medical supervision.

The instructions for the drug state that etatsizin can cause side effects, such as decreased contractility of the heart, deterioration of its coronary blood supply, arrhythmia and changes in the ECG, especially with long-term use or overdose. This may be due to drug interactions with other drugs, such as monoamine oxidase inhibitors (MAOIs) or quinidine antiarrhythmic drugs. Therefore, it is important to follow the dosage and take it under the supervision of a physician or cardiologist.

Intravenous administration of etatsizin is possible only under conditions of intensive medical supervision with ECG monitoring. It is recommended to avoid intravenous administration for a long time to avoid unwanted effects. Overall, this is an important drug that can help patients cope with many cardiovascular diseases, however, it should be taken under the supervision of a specialist and in accordance with recommendations.